Efficacy of palliative radiation therapy for symptomatic rectal cancer.
99 patients with symptomatic locally advanced rectal cancer who were treated with palliative radiation alone were reviewed. Dose-fractionation ranged from 18 to 54Gy. Response rate ranged from 62.5 to 86.7%, with a median response duration ranging 4.2-5.4months. Median survival was 6.9months. Using a BED cut-off of 39Gy10, no dose-response relationship was found.